Pharmaceutical
ChemLinkedChemicalFoodCosmeticPharmaceuticalJapanAgrochemicalSustainability
Notice of NMPA on Matters Related to Further Improving Drug Related Review, Approval and Supervision (2019 No. 56)
Request Notice of NMPA on Matters Related to Further Improving Drug Related Review, Approval and Supervision (2019 No. 56)
  • Local Title:国家药监局关于进一步完善药品关联审评审批和监管工作有关事宜的公告（2019年 第56号）
  • Country/Region:Chinese Mainland
  • Competent Authority: National Medical Products Administration (NMPA)
  • Type:Notice
  • Status:In force
  • Release Date:2019-07-16
  • Implementation Date:2019-07-16
Request
Document
Language Source Title Access
ZH Official 国家药监局关于进一步完善药品关联审评审批和监管工作有关事宜的公告（2019年 第56号） Download
Summary

The Notice of NMPA on Matters Related to Further Improving Drug Related Review, Approval and Supervision (2019 No. 56) was issued on Jul.16, 2019. It aims to further improving drug related review, approval and supervision, which includes:

1. General RequirementS

2. Product Registration Management

3. Use and Management of Original and Auxiliary Package Registration Information

4. Supervision and Administration

5. Others

Most Popular